trending Market Intelligence /marketintelligence/en/news-insights/trending/zkvJGTqSVtJGz-DWNihw-w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Karo Pharma closes offer to acquire Weifa shares

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Karo Pharma closes offer to acquire Weifa shares

Karo Pharma AB (publ) closed its voluntary offer to acquire all shares of Weifa ASA.

With 35,453,352 shares transferred to Karo Pharma, the company now holds 97.21% of the shares and voting rights in Weifa.

Karo Pharma will now effect a compulsory acquisition of the remaining shares in Weifa at 35 Norwegian kroner apiece as soon as possible.

As of Oct. 5, US$1 was equivalent to 7.99 Norwegian kroner.